我国主要少数民族医药防治缺血性心脏病研究概述  被引量:11

Major Chinese Ethnic Medicines for Prevention and Treatment of Ischemic Heart Diseases:A Review

在线阅读下载全文

作  者:徐季轩 马晓静 陈泓颖 高小力 佟海英 屠鹏飞 安超[2] 柴兴云 XU Jixuan;MA Xiaojing;CHEN Hongying;GAO Xiaoli;TONG Haiying;TU Pengfei;AN Chao;CHAI Xingyun(Beijing Research Institute of Chinese Medicine,School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing 100029,China;Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China)

机构地区:[1]北京中医药大学北京中医药研究院,中医学院,北京100029 [2]北京中医药大学东方医院,北京100078

出  处:《中国实验方剂学杂志》2022年第17期235-247,共13页Chinese Journal of Experimental Traditional Medical Formulae

基  金:国家自然科学基金项目(81774001)。

摘  要:我国缺血性心脏病发病率逐年增加,给家庭和社会造成了严重的负担,亟待寻找更好的治疗手段和医疗方案。基于象数思维、整体观等思维方式和临床经验,我国主要少数民族医药逐渐发展出独特的理论体系与治疗特色,在防治缺血性心脏病方面具有极大的应用潜力及研究价值。其中藏族医药(以下简称“藏医药”)、蒙古族医药(以下简称“蒙医药”)、傣族医药(以下简称“傣医药”)均可归属于以自然观与生命观为哲学基础的医学系统,各自发展出“三因”“三根”“四塔五蕴”理论,形成了对缺血性心脏病的独特认识并提出了相应的治法治则,产生了以三味檀香散、八味沉香散、肉蔻五味丸、雅叫哈顿散为代表的经典方剂,并具有以广枣、红景天、血竭为代表的特色民族药资源。笔者拟以藏医药、蒙医药为主,归纳民族医药防治缺血性心脏病的相关研究,并探讨开展该类研究所面临的机遇和挑战,以期为民族药防治缺血性心脏病的临床应用及新药开发研究提供参考。In China,the incidence of ischemic heart disease(IHD)is increasing year by year,which brings enormous burden to families and society.It is urgent to find preferable treatment methods and medical therapies.The Chinese ethnic minority medicine has gradually developed unique theoretical systems and therapeutic characteristics on the basis of clinical experience and thinking modes including image-number thinking and the holistic perspective.Consequently,it possesses huge application capacity and research value in prevention and treatment of IHD.Belonging to the medical system based on the view of nature and life,the Tibetan medicine,Mongolian medicine,and Dai medicine have respectively formed theories like "three elements" "three life-sustaining energies" "four elements and five skandhas(aggregates)",have put forward unique understandings of IHD and have formed corresponding therapeutic principles and methods,generating plentiful classic prescriptions represented by Sanwei Tanxiang powder,Bawei Chenxiang powder,Roukou Wuwei pills and Yajiao Hadun powder.They also contain characteristic ethnic medicine resources such as Choerospondiatis Fructus,Rhodiola Rosea and Draconis Sanguis.Aiming to provide enlightenment and reference for the clinical application and development of the Chinese ethnic minority medicine for the prevention and treatment of IHD,the authors try to summarize the related researches represented by Tibetan and Mongolian medicines,and then discuss the opportunities and challenges faced by such researches.

关 键 词:民族医药 缺血性心脏病 藏族药 蒙古族药 傣族药 基础研究 临床研究 

分 类 号:G353.11[文化科学—情报学] R28[医药卫生—中药学] R932[医药卫生—中医学] R972

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象